Background:Globally,the use of community pharmacies and pharmacists in the delivery of vaccination services has been hampered by several factors,laws,and regulations that do not support pharmacists to participate in t...Background:Globally,the use of community pharmacies and pharmacists in the delivery of vaccination services has been hampered by several factors,laws,and regulations that do not support pharmacists to participate in the delivery of vaccination services.With the advent of COVID-19 pandemic,many countries have included community pharmacists and pharmacies in vaccination services to improve coverage.This study described the delivery of vaccination services in community pharmacies using the COVID-19 experience and how their involvement impacted vaccination coverage in Nigeria.It also exposed how this experience can be used to support policy revisions to formally recognize pharmacists in immunization delivery.Methods:A descriptive cross-sectional study was conducted among 474 community pharmacists in two southwestern States in Nigeria,using a semi-structured questionnaire.It determines the number of community pharmacists who have been trained in the delivery of vaccination services,the types of vaccination services provided,and vaccines administered in their pharmacies.Data were analyzed with descriptive and inferential statistics and p-value at≤0.05.Results:Response rate was 86.7%.Less than half of the respondents(40.1%)had undergone vaccination training.Of the 129(31.4%)respondents that provide vaccination services,72(55.8%)administer vaccines in their pharmacies.Out of these 72 respondents;45(62.5%)were administering vaccines before their involvement in COVID-19 vaccine administration;57(79.2%)of the health personnel who administer vaccines were pharmacists;60(83.3%)of them administer vaccines on request;22(30.6%)administered COVID-19 vaccines only;and only 7(9.7%)of the respondents had administered over 500 doses of COVID-19 vaccines.Training in vaccination was associated with the vaccination services provided(p<0.05).Respondents suggested government support through legal framework and policy review,training and empowering pharmacists in vaccine administration,and recognition of community pharmacists as PHC providers.展开更多
Objective:To assess the complete vaccination coverage and timeliness of childhood vaccinations among Indigenous children in Peninsular Malaysia.Methods:The study utilized data from the 2022 Orang Asli Health Survey,a ...Objective:To assess the complete vaccination coverage and timeliness of childhood vaccinations among Indigenous children in Peninsular Malaysia.Methods:The study utilized data from the 2022 Orang Asli Health Survey,a cross-sectional survey conducted among a representative sample of Orang Asli in Peninsular Malaysia.A total of 68 villages were randomly selected from a pool of 853 villages,encompassing diverse geographic and sociodemographic contexts with a total of 15950 respondents Orang Asli successfully interviewed.However,this study only utilized data from surveyed children aged 12 to 59 months with a total of 1551 children included.Validated structured questionnaires were used to collect sociodemographic data and health status,with nurses verifying vaccination records.Children who received all nine primary vaccinations were defined as having complete vaccination while those who received vaccine within the recommended time were defined as having timely vaccination.Data analysis was conducted using IBM SPSS version 25.0,focusing on descriptive analyses of children's vaccination status.Results:The prevalence of overall complete vaccination among Indigenous children was 87.7%,while timely vaccination was only 40.3%.The prevalence of complete vaccination for Bacillus Calmette-Guérin(BCG),the first dose of hepatitis B,three doses of DTaP-IPV-Hib,and measles,mumps,and rubella(MMR)was above 95.0%,except for the second and third doses of hepatitis B.The prevalence of timely vaccination ranged from above 95.0%for vaccines given at birth,gradually decreasing with increasing age to 57.5%for the first dose of MMR.Moreover,the completion rates for three doses of DtaP-IPV-Hib and the initial dose of MMR surpassed 90%among Indigenous children aged 12-23 months,yet the timeliness remained at a moderate level.Conclusions:While the overall complete vaccination coverage among Indigenous children in Malaysia is relatively high,there are concerning disparities in the timeliness of vaccination,particularly as children age.展开更多
Influenza is a significant global public health challenge,with seasonal epidemics imposing substantial burdens on healthcare systems and vulnerable populations,causing 3 to 5 million severe cases and 290,000 to 650,00...Influenza is a significant global public health challenge,with seasonal epidemics imposing substantial burdens on healthcare systems and vulnerable populations,causing 3 to 5 million severe cases and 290,000 to 650,000 respiratory-related deaths worldwide each year[1].Vaccines are an effective means of preventing influenza.In recent years,China has made progress in vaccine development and immunization strategies.The population is recommended to receive influenza vaccines annually;however,their coverage remain suboptimal[2].The World Health Organization(WHO)highlights that all countries should consider implementing seasonal influenza immunization programs,with priority groups determined based on local epidemiological contexts.In alignment with the Immunization Agenda 2030,the use of seasonal influenza vaccines contributes to strengthening the life course of immunization and serves as a critical component for addressing influenza pandemics,as outlined in the WHO Global Influenza Strategy 2019-2030.展开更多
碳捕集与封存(Carbon capture and storage, CCS)的投资决策研究大多聚焦于单一企业的不足,从燃煤电厂角度出发,描述了两家投资主体参与市场竞争的“双寡头”情况;同时,考虑了碳价和技术创新双重不确定的影响,将碳配额和政府补贴作为鼓...碳捕集与封存(Carbon capture and storage, CCS)的投资决策研究大多聚焦于单一企业的不足,从燃煤电厂角度出发,描述了两家投资主体参与市场竞争的“双寡头”情况;同时,考虑了碳价和技术创新双重不确定的影响,将碳配额和政府补贴作为鼓励投资的激励政策,构建了CCS改造投资的实物期权评价模型。通过逆向归纳法,分别得出垄断情况和双寡头情况下的投资价值和投资临界值。研究表明:抢占投资会造成投资者的短视行为,碳价波动率、碳捕获率、技术创新幅度等参数的增大会减缓投资,政府补贴和技术创新概率的增大则会加速投资。展开更多
文摘Background:Globally,the use of community pharmacies and pharmacists in the delivery of vaccination services has been hampered by several factors,laws,and regulations that do not support pharmacists to participate in the delivery of vaccination services.With the advent of COVID-19 pandemic,many countries have included community pharmacists and pharmacies in vaccination services to improve coverage.This study described the delivery of vaccination services in community pharmacies using the COVID-19 experience and how their involvement impacted vaccination coverage in Nigeria.It also exposed how this experience can be used to support policy revisions to formally recognize pharmacists in immunization delivery.Methods:A descriptive cross-sectional study was conducted among 474 community pharmacists in two southwestern States in Nigeria,using a semi-structured questionnaire.It determines the number of community pharmacists who have been trained in the delivery of vaccination services,the types of vaccination services provided,and vaccines administered in their pharmacies.Data were analyzed with descriptive and inferential statistics and p-value at≤0.05.Results:Response rate was 86.7%.Less than half of the respondents(40.1%)had undergone vaccination training.Of the 129(31.4%)respondents that provide vaccination services,72(55.8%)administer vaccines in their pharmacies.Out of these 72 respondents;45(62.5%)were administering vaccines before their involvement in COVID-19 vaccine administration;57(79.2%)of the health personnel who administer vaccines were pharmacists;60(83.3%)of them administer vaccines on request;22(30.6%)administered COVID-19 vaccines only;and only 7(9.7%)of the respondents had administered over 500 doses of COVID-19 vaccines.Training in vaccination was associated with the vaccination services provided(p<0.05).Respondents suggested government support through legal framework and policy review,training and empowering pharmacists in vaccine administration,and recognition of community pharmacists as PHC providers.
文摘Objective:To assess the complete vaccination coverage and timeliness of childhood vaccinations among Indigenous children in Peninsular Malaysia.Methods:The study utilized data from the 2022 Orang Asli Health Survey,a cross-sectional survey conducted among a representative sample of Orang Asli in Peninsular Malaysia.A total of 68 villages were randomly selected from a pool of 853 villages,encompassing diverse geographic and sociodemographic contexts with a total of 15950 respondents Orang Asli successfully interviewed.However,this study only utilized data from surveyed children aged 12 to 59 months with a total of 1551 children included.Validated structured questionnaires were used to collect sociodemographic data and health status,with nurses verifying vaccination records.Children who received all nine primary vaccinations were defined as having complete vaccination while those who received vaccine within the recommended time were defined as having timely vaccination.Data analysis was conducted using IBM SPSS version 25.0,focusing on descriptive analyses of children's vaccination status.Results:The prevalence of overall complete vaccination among Indigenous children was 87.7%,while timely vaccination was only 40.3%.The prevalence of complete vaccination for Bacillus Calmette-Guérin(BCG),the first dose of hepatitis B,three doses of DTaP-IPV-Hib,and measles,mumps,and rubella(MMR)was above 95.0%,except for the second and third doses of hepatitis B.The prevalence of timely vaccination ranged from above 95.0%for vaccines given at birth,gradually decreasing with increasing age to 57.5%for the first dose of MMR.Moreover,the completion rates for three doses of DtaP-IPV-Hib and the initial dose of MMR surpassed 90%among Indigenous children aged 12-23 months,yet the timeliness remained at a moderate level.Conclusions:While the overall complete vaccination coverage among Indigenous children in Malaysia is relatively high,there are concerning disparities in the timeliness of vaccination,particularly as children age.
基金supported by the Chinese Association of Preventive Medicine-Vaccine and Immunization Youth Talent Support Project(CPMAQT-YM0314)。
文摘Influenza is a significant global public health challenge,with seasonal epidemics imposing substantial burdens on healthcare systems and vulnerable populations,causing 3 to 5 million severe cases and 290,000 to 650,000 respiratory-related deaths worldwide each year[1].Vaccines are an effective means of preventing influenza.In recent years,China has made progress in vaccine development and immunization strategies.The population is recommended to receive influenza vaccines annually;however,their coverage remain suboptimal[2].The World Health Organization(WHO)highlights that all countries should consider implementing seasonal influenza immunization programs,with priority groups determined based on local epidemiological contexts.In alignment with the Immunization Agenda 2030,the use of seasonal influenza vaccines contributes to strengthening the life course of immunization and serves as a critical component for addressing influenza pandemics,as outlined in the WHO Global Influenza Strategy 2019-2030.
文摘碳捕集与封存(Carbon capture and storage, CCS)的投资决策研究大多聚焦于单一企业的不足,从燃煤电厂角度出发,描述了两家投资主体参与市场竞争的“双寡头”情况;同时,考虑了碳价和技术创新双重不确定的影响,将碳配额和政府补贴作为鼓励投资的激励政策,构建了CCS改造投资的实物期权评价模型。通过逆向归纳法,分别得出垄断情况和双寡头情况下的投资价值和投资临界值。研究表明:抢占投资会造成投资者的短视行为,碳价波动率、碳捕获率、技术创新幅度等参数的增大会减缓投资,政府补贴和技术创新概率的增大则会加速投资。
